Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vascular Graft Solutions

Request full access

Develops innovative solutions to improve the outcome of bypass surgery and patients’ quality of life

Tel Aviv-Yafo, IsraelFounded 2009Health Tech & Medtech

About Vascular Graft Solutions

Vascular Graft Solutions (VGS), established in 2009, focuses on improving coronary revascularization procedures through innovative technologies. Operating in the medical device industry, VGS primarily serves cardiac surgeons and healthcare providers involved in coronary artery bypass grafting (CABG). The company aims to enhance both short and long-term outcomes of CABG, a widely performed cardiac surgery, by providing external support for vein grafts. VGS's business model revolves around the development, clinical validation, and commercialization of its patented devices, which are FDA cleared and CE marked for sale in various regions including the US, Europe, Australia, Israel, and Mexico. Revenue is generated through the sale of these medical devices to hospitals and healthcare facilities. VGS's mission is to advance the standard of care in coronary bypass surgery, focusing on improving patient quality of life and reducing the economic burden on healthcare systems.

Source: Dealroom company data

At a glance

Status
Operational
Employees
18
Open positions
None listed
Dealroom signal
71.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
medical implants, Surgery, Cardiology and cardiovascular, Patient Care, Spinout, Hospital, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC May 2024 $12M $48M Undisclosed —
SERIES C✓Equity / VC Jan 2022 $12M $48M Undisclosed —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Vascular Graft Solutions website traffic

Latest recorded traffic for Vascular Graft Solutions is 400 monthly website visits, down 57.9% over the last three months. Vascular Graft Solutions's team grew 5.9% over the past year.

Latest monthly visits400 3-month web change-57.9% 1-year team growth+5.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vascular Graft Solutions in the Tel Aviv-Yafo ecosystem

Live from Dealroom

The Vascular Graft Solutions office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Champel Capital

Series B and later1 investor entered at this stage

  • Broadview Ventures

Other known investors6 additional known investors

  • Tel Aviv University
  • Akilia Partners
  • Medison Ventures
  • Pontifax Funds
  • RAD BioMed
  • Tal Ventures
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Vascular Graft Solutions’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.